Raymond James Financial Services Advisors Inc. Sells 5,125 Shares of Maximus, Inc. (NYSE:MMS)

Raymond James Financial Services Advisors Inc. lessened its stake in shares of Maximus, Inc. (NYSE:MMSGet Rating) by 18.4% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 22,730 shares of the health services provider’s stock after selling 5,125 shares during the period. Raymond James Financial Services Advisors Inc.’s holdings in Maximus were worth $1,315,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. BlackRock Inc. boosted its position in Maximus by 1.1% during the first quarter. BlackRock Inc. now owns 7,014,024 shares of the health services provider’s stock worth $525,701,000 after purchasing an additional 74,106 shares during the period. Victory Capital Management Inc. boosted its holdings in shares of Maximus by 7.8% during the 2nd quarter. Victory Capital Management Inc. now owns 5,672,770 shares of the health services provider’s stock worth $354,604,000 after buying an additional 408,672 shares during the period. FMR LLC grew its stake in Maximus by 3.0% in the 2nd quarter. FMR LLC now owns 2,973,346 shares of the health services provider’s stock valued at $185,863,000 after buying an additional 86,604 shares during the last quarter. State Street Corp raised its holdings in Maximus by 2.3% in the 2nd quarter. State Street Corp now owns 2,587,930 shares of the health services provider’s stock worth $161,772,000 after acquiring an additional 57,997 shares during the period. Finally, Mondrian Investment Partners LTD lifted its position in Maximus by 1.9% during the 3rd quarter. Mondrian Investment Partners LTD now owns 1,173,933 shares of the health services provider’s stock worth $67,936,000 after acquiring an additional 21,343 shares during the last quarter. Institutional investors and hedge funds own 97.41% of the company’s stock.

Insider Activity

In other news, Director Raymond B. Ruddy bought 5,730 shares of Maximus stock in a transaction that occurred on Wednesday, December 7th. The stock was purchased at an average cost of $69.91 per share, with a total value of $400,584.30. Following the completion of the transaction, the director now directly owns 109,030 shares in the company, valued at $7,622,287.30. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, General Counsel David Francis sold 1,800 shares of the company’s stock in a transaction dated Wednesday, November 23rd. The shares were sold at an average price of $70.92, for a total value of $127,656.00. Following the sale, the general counsel now owns 13,658 shares of the company’s stock, valued at $968,625.36. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Raymond B. Ruddy purchased 5,730 shares of the company’s stock in a transaction that occurred on Wednesday, December 7th. The stock was acquired at an average cost of $69.91 per share, with a total value of $400,584.30. Following the transaction, the director now directly owns 109,030 shares of the company’s stock, valued at $7,622,287.30. The disclosure for this purchase can be found here. 1.10% of the stock is currently owned by company insiders.

Analyst Ratings Changes

MMS has been the topic of several research analyst reports. TheStreet raised Maximus from a “c+” rating to a “b-” rating in a research report on Thursday, December 8th. StockNews.com initiated coverage on Maximus in a report on Wednesday, October 12th. They issued a “hold” rating on the stock.

Maximus Trading Down 1.8 %

Shares of Maximus stock opened at $72.03 on Friday. Maximus, Inc. has a 1 year low of $54.46 and a 1 year high of $79.78. The company’s fifty day simple moving average is $70.73 and its 200-day simple moving average is $64.47. The company has a market cap of $4.38 billion, a price-to-earnings ratio of 21.89 and a beta of 0.70. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.83.

Maximus (NYSE:MMSGet Rating) last announced its quarterly earnings data on Monday, November 21st. The health services provider reported $1.40 EPS for the quarter, beating analysts’ consensus estimates of $1.02 by $0.38. Maximus had a net margin of 4.40% and a return on equity of 17.59%. The business had revenue of $1.18 billion during the quarter, compared to analyst estimates of $1.09 billion. As a group, sell-side analysts expect that Maximus, Inc. will post 3.9 EPS for the current year.

Maximus Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 28th. Stockholders of record on Wednesday, February 15th will be given a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.55%. The ex-dividend date is Tuesday, February 14th. Maximus’s dividend payout ratio is presently 34.04%.

Maximus Profile

(Get Rating)

MAXIMUS, Inc engages in the operation of government health and human services programs, and the provision of technology solutions to government. It operates through the following segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers business process services (BPS), appeals and assessments, and related consulting work for U.S.

Read More

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSGet Rating).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.